Nanotechnology

Nanotechnology
Driving the future of organ development

Alexander M. Seifalian,

A Professor of Nanotechnology and Regenerative Medicine, and Director of UCL Centre for Nanotechnology & Regenerative Medicine at University College London. Alex completed his education at University of London and University College London Medical School. He is a Fellow of the Institute of Nanotechnology (FIoN) and Fellow of Society of Biology (FSB), and has published over 400 peer-reviewed research papers, 31 book chapter contributions and 10 families of UK and International patents.

Alex has led and managed many large projects with multidisciplinary teams with very successful outcomes in terms of commercialisation and translation to patients. His current projects have led to the development of cardiovascular implants using nanomaterials and stem cell technology, and the development of organs using tissue engineering and nanoparticles for detection and treatment of cancer. He has also developed a family of nanomaterials and nanocomposite polymers for a range of biomedical applications.

Alex was awarded the top prize in the field for development of nanomaterials and technologies for cardiovascular implants in 2007 by Medical Future Innovation, in 2009 received a Business Innovation Award from UK Trade & Investment (UKTI) in the Life Sciences and Healthcare category and in 2012 Winner of most innovative new product 2012 "synthetic trachea" awarded by European Life Science, Hamburg, Germany, and in 2013 was acknowledged by the international community for his outstanding achievements in Nanoscience and Nanotechnology with the prestigious Nanosmat prize award in Granada, Spain.

More recently (2011), Alex has developed a lacrimal drainage conduit, vascular bypass graft, and world's first synthetic trachea made from nanocomposite polymers and stem cells and delivered them from the laboratory directly to human patients.

RSVP: By 14:30 on Sunday 12th January 2014 Via: events@anjoman.co.uk